# Computerized Behavioral Therapy Device For The Treatment Of Fibromyalgia Symptoms
> **Product code: QWI** · Class II — Moderate Risk (510(k) clearance required) · Neurology · 21 CFR 882.5804
## Classification
- **FDA Product Code:** QWI
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 882.5804
- **Review panel:** PM
- **Medical specialty:** Neurology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

Provides acceptance and commitment therapy (ACT), a form of cognitive behavioral therapy (CBT), for patients with fibromyalgia symptoms

## Market data
- **Cleared 510(k) submissions:** 1
- **Registered establishments:** 1
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=QWI)
---
*AI Analytics · CC0 1.0*